BUZZ-U.S. STOCKS ON THE MOVE-Vanda Pharma, Chesapeake, China Finance

Tue Dec 23, 2014 7:27am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter,; for the Morning News Call newsletter,

U.S. stock index e-mini futures were up on Tuesday: Dow Jones industrial average futures were up 0.16 percent at 17,925, S&P 500 futures were up 0.11 percent at 2,074.75 and Nasdaq 100 futures were up 0.16 percent at 4,298.5.

** VANDA PHARMACEUTICALS INC, Monday close $11.91, +17.55 pct premarket

The drugmaker settled a license dispute with Novartis AG over its schizophrenia drug, Fanapt. Vanda will regain U.S. and Canada rights to Fanapt and get exclusive worldwide license for similar drug, AQW051, from Novartis. Under the settlement, Novartis will buy Vanda shares worth $25 million at $13.82 per share.

** CHESAPEAKE ENERGY CORP, Monday close $18.42, +5.48 pct premarket

The oil and gas company authorized a $1 billion stock buyback program and also closed sale of some of its oil and gas assets in Marcellus and Utica shale fields to Southwestern Energy Co for $4.97 billion.